Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Autolus Therapeutics plc | StockGist | StockGist

Companies
AUTL
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings AUTLSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Autolus Therapeutics plc

Filed May 12, 2025

Accepted May 11, 2025, 8:00 PM ET

CIK 0001730463

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

Autolus Therapeutics plc

Person Type

HC

CUSIP: 05280R100

Amendment History

7 filings

SCHEDULE 13G
Original
Nov 14, 20250001172661-25-005172
SCHEDULE 13G/A
Amendment 1
Apr 4, 20250000902219-25-000146
SCHEDULE 13G/A
Amendment 2
May 7, 20250000950170-25-065100
SCHEDULE 13G/A
Amendment 3
Viewing
May 12, 20250000315066-25-001441
SCHEDULE 13G/A
Amendment 4
Nov 14, 20250001172661-25-004821
SCHEDULE 13G/A
Amendment 5
Feb 13, 20260001019056-26-000041
SCHEDULE 13G/A
Amendment 6
Latest
Feb 17, 20260001172661-26-001258

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

Autolus Therapeutics plc1 weeks ago

Autolus Therapeutics plc1 months ago

Autolus Therapeutics plc1 months ago

Autolus Therapeutics plc2 months ago

Autolus Therapeutics plc2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice